Showing results (311-320 of 351) with videos related to

Sort By:
Pageof 36
Antimicrobial Agents and Chemotherapy|February 18, 2016
Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough ConcentrationsM A Encalada Ventura, M J P van Wanrooy, L F R Span, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2018
Population Pharmacokinetic Model and Limited Sampling Strategies for Personalized Dosing of Levofloxacin in Tuberculosis PatientsSimone H J van den Elsen, Marieke G G Sturkenboom, Natasha Van't Boveneind-Vrubleuskaya, et al.
Therapeutic Drug Monitoring|November 14, 2015
Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal DiseaseKim C M van der Elst, Charlie H S Brouwers, Edwin R van den Heuvel, et al.
BMJ Open|March 28, 2022
Malnutrition assessment methods in adult patients with tuberculosis: a systematic reviewLies Ter Beek, Mathieu S Bolhuis, Harriët Jager-Wittenaar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 25, 2020
How to design a study to evaluate therapeutic drug monitoring in infectious diseases?A-G Märtson, M G G Sturkenboom, J Stojanova, et al.
European Journal of Human Genetics : EJHG|June 30, 2016
Genetic screening of Congenital Short Bowel Syndrome patients confirms CLMP as the major gene involved in the recessive form of this disorderMaria M Alves, Danny Halim, Reza Maroofian, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2017
Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive CandidiasisJ M Boonstra, K C van der Elst, A Veringa, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant TuberculosisS P van Rijn, M A Zuur, R van Altena, et al.
Medical Microbiology and Immunology|November 13, 2012
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccinesSatria A Prabowo, Matthias I Gröschel, Ed D L Schmidt, et al.
Clinical and Diagnostic Laboratory Immunology|March 12, 2004
Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemicDaniel M N Okenu, Lazarus O Ofielu, Kirk A Easley, et al.
Pageof 36